Drug | Synergist concentration (ng/ml) | Mean survival time (95% CI) | 10-day % mortality |
---|---|---|---|
Voriconazole | Â | Â | Â |
 Control |  | 8.5 (8.0–9.1) | 21.9 |
 Ivermectin |  | 8.0 (7.5–8.5) | 35.0 |
 IVM + VOR A | 3667 | 5.4 (4.9–5.9) | 59.8 |
 IVM + VOR B | 2750 | 5.7 (5.3–6.0) | 44.9 |
 IVM + VOR C | 1833 | 7.6 (7.0–8.1) | 42.2 |
 IVM + VOR D | 916 | 7.4 (6.9–7.8) | 34.7 |
Ritonavir | Â | Â | Â |
 Control |  | 8.0 (7.5–8.4) | 18.3 |
 Ivermectin |  | 8.2 (7.7–8.8) | 30.3 |
 IVM + RIF A | 11,000 | 6.8 (6.1–7.5) | 53.7 |
 IVM + RIF B | 8250 | 6.6 (5.8–7.4) | 51.8 |
 IVM + RIF C | 5500 | 6.7 (6.1–7.3) | 55.2 |
 IVM + RIF D | 2750 | 7.3 (6.7–8.0) | 42.3 |
Cobicistat | Â | Â | Â |
 Control |  | 7.1 (6.8–7.5) | 18.5 |
 Ivermectin |  | 7.8 (7.1–8.4) | 45.6 |
 IVM + COB A | 990 | 8.6 (8.1–9.1) | 23.6 |
 IVM + COB B | 742 | 8.2 (7.8–8.7) | 29.6 |
 IVM + COB C | 495 | 7.5 (6.9–8.1) | 39.0 |
 IVM + COB D | 247 | 8.1 (7.6–8.6) | 30.8 |
Elacridar | Â | Â | Â |
 Control |  | 9.5 (9.3–9.8) | 12.2 |
 Ivermectin |  | 7.1 (6.5–7.6) | 54.6 |
 IVM + ELA A | 160 | 6.9 (6.4–7.4) | 62.3 |
 IVM + ELA B | 120 | 7.3 (6.8–7.8) | 49.6 |
 IVM + ELA C | 80 | 6.5 (6.1–7.0) | 51.4 |
 IVM + ELA D | 40 | 7.0 (6.5–7.4) | 56.1 |
Cyclosporine A | Â | Â | Â |
 Control |  | 9.0 (8.3–9.6) | 15.6 |
 Ivermectin |  | 9.0 (8.5–9.6) | 21.8 |
 IVM + CYC A | 1802 | 7.8 (6.8–8.8) | 34.7 |
 IVM + CYC B | 1351 | 7.7 (6.8–8.6) | 38.1 |
 IVM + CYC C | 901 | 7.7 (7.0–8.4) | 20.9 |
 IVM + CYC D | 450 | 8.5 (7.9–9.2) | 33.3 |
Rifampicin | Â | Â | Â |
 Control |  | 7.2 (6.6–7.7) | 39.1 |
 Ivermectin |  | 6.7 (6.0–7.5) | 53.4 |
 IVM + RIF A | 7000 | 6.9 (6.2–7.6) | 49.5 |
 IVM + RIF B | 5250 | 6.4 (5.6–7.1) | 61.3 |
 IVM + RIF C | 3500 | 8.2 (7.6–8.9) | 31.5 |
 IVM + RIF D | 1750 | 6.4 (5.8–7–0) | 66.3 |